Medical and surgical palliative care of patients with urological malignancies

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Purpose: Urological malignancies are relatively common and patients often live many years with disease. There are many effective medical and surgical palliative treatments, although few comprehensive guidelines have been published. We reviewed the various palliative treatments available for the 3 most common urological malignancies, namely prostate cancer, bladder cancer and renal cancer. Materials and Methods: A literature search of the last 15 years was performed using MEDLINE/PubMed. In addition, relevant journals were targeted for specific information related to this review. Our clinical experience was combined with the current literature to create guidelines for palliative care. Results: Several effective treatments are available for the palliative care of patients with prostate, bladder or renal cancer. Options in palliative care are varied with regard to invasiveness, morbidity, risks and benefits. The algorithms described provide a framework to a sequential approach to achieving palliation. Urologists are central to initiating care and referrals to improve outcomes in these patients. Conclusions: Palliative care includes disease directed treatment as well as functional, psychosocial and spiritual support. Disease directed therapy and palliative care should be provided simultaneously throughout illness. Improved quality of care and quality of life as well as physician satisfaction are frequent outcomes of this approach. Supportive care begins at initial diagnosis and it should be flexible to meet the changing needs of patients with cancer and their families.

Original languageEnglish (US)
Pages (from-to)1177-1182
Number of pages6
JournalJournal of Urology
Volume174
Issue number4 I
DOIs
StatePublished - Oct 2005

Fingerprint

Palliative Care
Neoplasms
Urinary Bladder Neoplasms
Kidney Neoplasms
Prostatic Neoplasms
Guidelines
Quality of Health Care
PubMed
MEDLINE
Therapeutics
Referral and Consultation
Quality of Life
Morbidity
Physicians

Keywords

  • Bladder neoplasms
  • Kidney neoplasms
  • Pain
  • Palliative care
  • Prostatic neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Medical and surgical palliative care of patients with urological malignancies. / Ok, Joon Ha; Meyers, Frederick J; Evans, Christopher P.

In: Journal of Urology, Vol. 174, No. 4 I, 10.2005, p. 1177-1182.

Research output: Contribution to journalArticle

@article{112dca71afce4e0a9a06cd6dcc3047de,
title = "Medical and surgical palliative care of patients with urological malignancies",
abstract = "Purpose: Urological malignancies are relatively common and patients often live many years with disease. There are many effective medical and surgical palliative treatments, although few comprehensive guidelines have been published. We reviewed the various palliative treatments available for the 3 most common urological malignancies, namely prostate cancer, bladder cancer and renal cancer. Materials and Methods: A literature search of the last 15 years was performed using MEDLINE/PubMed. In addition, relevant journals were targeted for specific information related to this review. Our clinical experience was combined with the current literature to create guidelines for palliative care. Results: Several effective treatments are available for the palliative care of patients with prostate, bladder or renal cancer. Options in palliative care are varied with regard to invasiveness, morbidity, risks and benefits. The algorithms described provide a framework to a sequential approach to achieving palliation. Urologists are central to initiating care and referrals to improve outcomes in these patients. Conclusions: Palliative care includes disease directed treatment as well as functional, psychosocial and spiritual support. Disease directed therapy and palliative care should be provided simultaneously throughout illness. Improved quality of care and quality of life as well as physician satisfaction are frequent outcomes of this approach. Supportive care begins at initial diagnosis and it should be flexible to meet the changing needs of patients with cancer and their families.",
keywords = "Bladder neoplasms, Kidney neoplasms, Pain, Palliative care, Prostatic neoplasms",
author = "Ok, {Joon Ha} and Meyers, {Frederick J} and Evans, {Christopher P}",
year = "2005",
month = "10",
doi = "10.1097/01.ju.0000173077.84274.01",
language = "English (US)",
volume = "174",
pages = "1177--1182",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4 I",

}

TY - JOUR

T1 - Medical and surgical palliative care of patients with urological malignancies

AU - Ok, Joon Ha

AU - Meyers, Frederick J

AU - Evans, Christopher P

PY - 2005/10

Y1 - 2005/10

N2 - Purpose: Urological malignancies are relatively common and patients often live many years with disease. There are many effective medical and surgical palliative treatments, although few comprehensive guidelines have been published. We reviewed the various palliative treatments available for the 3 most common urological malignancies, namely prostate cancer, bladder cancer and renal cancer. Materials and Methods: A literature search of the last 15 years was performed using MEDLINE/PubMed. In addition, relevant journals were targeted for specific information related to this review. Our clinical experience was combined with the current literature to create guidelines for palliative care. Results: Several effective treatments are available for the palliative care of patients with prostate, bladder or renal cancer. Options in palliative care are varied with regard to invasiveness, morbidity, risks and benefits. The algorithms described provide a framework to a sequential approach to achieving palliation. Urologists are central to initiating care and referrals to improve outcomes in these patients. Conclusions: Palliative care includes disease directed treatment as well as functional, psychosocial and spiritual support. Disease directed therapy and palliative care should be provided simultaneously throughout illness. Improved quality of care and quality of life as well as physician satisfaction are frequent outcomes of this approach. Supportive care begins at initial diagnosis and it should be flexible to meet the changing needs of patients with cancer and their families.

AB - Purpose: Urological malignancies are relatively common and patients often live many years with disease. There are many effective medical and surgical palliative treatments, although few comprehensive guidelines have been published. We reviewed the various palliative treatments available for the 3 most common urological malignancies, namely prostate cancer, bladder cancer and renal cancer. Materials and Methods: A literature search of the last 15 years was performed using MEDLINE/PubMed. In addition, relevant journals were targeted for specific information related to this review. Our clinical experience was combined with the current literature to create guidelines for palliative care. Results: Several effective treatments are available for the palliative care of patients with prostate, bladder or renal cancer. Options in palliative care are varied with regard to invasiveness, morbidity, risks and benefits. The algorithms described provide a framework to a sequential approach to achieving palliation. Urologists are central to initiating care and referrals to improve outcomes in these patients. Conclusions: Palliative care includes disease directed treatment as well as functional, psychosocial and spiritual support. Disease directed therapy and palliative care should be provided simultaneously throughout illness. Improved quality of care and quality of life as well as physician satisfaction are frequent outcomes of this approach. Supportive care begins at initial diagnosis and it should be flexible to meet the changing needs of patients with cancer and their families.

KW - Bladder neoplasms

KW - Kidney neoplasms

KW - Pain

KW - Palliative care

KW - Prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=24944569249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944569249&partnerID=8YFLogxK

U2 - 10.1097/01.ju.0000173077.84274.01

DO - 10.1097/01.ju.0000173077.84274.01

M3 - Article

C2 - 16145365

AN - SCOPUS:24944569249

VL - 174

SP - 1177

EP - 1182

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4 I

ER -